NCT05349123

Brief Summary

The Mindful Breathing Laboratory under the direction of Dr. Benzo will complete a randomized controlled trial to evaluate the mindful breathing module. This rigorous study will evaluate home-based PR system compared to the home-based PR system plus mindful breathing module for its effects on breathlessness and emotions. The investigators hypothesize that the intervention will decrease breathlessness while increasing emotional perception, emotional intelligence, and mindfulness.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
99

participants targeted

Target at P50-P75 for not_applicable chronic-obstructive-pulmonary-disease

Timeline
Completed

Started Jan 2022

Typical duration for not_applicable chronic-obstructive-pulmonary-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 10, 2022

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 22, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

April 27, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 7, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 7, 2024

Completed
1.1 years until next milestone

Results Posted

Study results publicly available

June 6, 2025

Completed
Last Updated

June 6, 2025

Status Verified

May 1, 2025

Enrollment Period

2.3 years

First QC Date

April 22, 2022

Results QC Date

May 2, 2025

Last Update Submit

May 19, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Breathlessness

    Breathlessness as measured by the Chronic Respiratory Disease Questionnaire. The Chronic Respiratory Disease Questionnaire is a 20-question inventory assessing four areas, including dyspnea (breathlessness). Patients rate their experience numerically on a 7-point modified Likert scale of 1 to7 with higher ratings indicating less symptom impairment. Scores are obtained by adding the scores for the items that make up each category and dividing by the number of items. A minimally important difference is a change in score of 0.5 or more.

    baseline, 3 months, 6 months

  • Emotion

    Emotion as measured by the Chronic Respiratory Disease Questionnaire. The Chronic Respiratory Disease Questionnaire is a 20-question inventory assessing four areas, including emotion. Patients rate their experience numerically on a 7-point modified Likert scale of 1 to7 with higher ratings indicating less symptom impairment. Scores are obtained by adding the scores for the items that make up each category and dividing by the number of items. A minimally important difference is a change in score of 0.5 or more.

    baseline, 3 months, 6 months

Secondary Outcomes (1)

  • Physical Activity

    baseline, 3 months, 6 months

Study Arms (2)

Intervention

EXPERIMENTAL

Home-based pulmonary rehabilitation that includes health coaching with mindful breathing module

Behavioral: Mindful BreathingBehavioral: Home-Based Pulmonary Rehabilitation

Control

ACTIVE COMPARATOR

Home-based pulmonary rehabilitation that includes health coaching

Behavioral: Home-Based Pulmonary Rehabilitation

Interventions

Subject will be expected to do 12 weeks of home-based rehabilitation, 6 days a week in their home. The proposed project explores the addition of a mindful breathing module, which involves daily guided breathing practice with feedback to encourage mindful breathing.

Intervention

Subject will be asked to complete exercise guided by a video six days a week and to complete mindful walking six days per week. They will receive weekly health coaching calls.

Also known as: Health Coaching
ControlIntervention

Eligibility Criteria

Age40 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients must be ≥40 years old
  • Patients must have a diagnosis COPD documented by pulmonary function testing; breathlessness of score 2 or higher by the Medical Research Council Score
  • Patients must be a current or previous smoker with at least 10 pack-years of cigarette smoking

You may not qualify if:

  • Patients with a high likelihood of being lost to follow-up or contact (patients with active chemical dependency), are planning to move out of the state; or are not living in the healthcare area
  • Patients with an inability to provide good data or follow commands (patients who are disoriented, have a severe neurologic or psychiatric condition)
  • Patients with an inability to do mild exercise (patients who have orthopedic-neurologic problems; patients who have severe heart failure, characterized by an ejection fraction of \<20% or by New York Heart Association Class IV disease; patients who should be at complete rest, confined to a bed or chair; or patients in whom any physical activity brings on discomfort and in whom symptoms occur at rest).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Mayo Clinic Rochester

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Pulmonary Disease, Chronic Obstructive

Condition Hierarchy (Ancestors)

Lung Diseases, ObstructiveLung DiseasesRespiratory Tract DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Results Point of Contact

Title
Roberto P Benzo
Organization
Mayo Clinic

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Since the patients will know if they have the Pursed Lipped Breathing Application and Spire tags, the outcome assessor will be blinded to which arm received the Application and tags.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Half of the subjects will be randomized to receive home-based PR with the mindful breathing module (intervention group) and half will receive home-based PR (control group).
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 22, 2022

First Posted

April 27, 2022

Study Start

January 10, 2022

Primary Completion

May 7, 2024

Study Completion

May 7, 2024

Last Updated

June 6, 2025

Results First Posted

June 6, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations